PMID- 21559511 OWN - NLM STAT- MEDLINE DCOM- 20111128 LR - 20220316 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 6 IP - 4 DP - 2011 Apr 29 TI - Comparison of three targeted enrichment strategies on the SOLiD sequencing platform. PG - e18595 LID - 10.1371/journal.pone.0018595 [doi] LID - e18595 AB - Despite the ever-increasing throughput and steadily decreasing cost of next generation sequencing (NGS), whole genome sequencing of humans is still not a viable option for the majority of genetics laboratories. This is particularly true in the case of complex disease studies, where large sample sets are often required to achieve adequate statistical power. To fully leverage the potential of NGS technology on large sample sets, several methods have been developed to selectively enrich for regions of interest. Enrichment reduces both monetary and computational costs compared to whole genome sequencing, while allowing researchers to take advantage of NGS throughput. Several targeted enrichment approaches are currently available, including molecular inversion probe ligation sequencing (MIPS), oligonucleotide hybridization based approaches, and PCR-based strategies. To assess how these methods performed when used in conjunction with the ABI SOLID3+, we investigated three enrichment techniques: Nimblegen oligonucleotide hybridization array-based capture; Agilent SureSelect oligonucleotide hybridization solution-based capture; and Raindance Technologies' multiplexed PCR-based approach. Target regions were selected from exons and evolutionarily conserved areas throughout the human genome. Probe and primer pair design was carried out for all three methods using their respective informatics pipelines. In all, approximately 0.8 Mb of target space was identical for all 3 methods. SOLiD sequencing results were analyzed for several metrics, including consistency of coverage depth across samples, on-target versus off-target efficiency, allelic bias, and genotype concordance with array-based genotyping data. Agilent SureSelect exhibited superior on-target efficiency and correlation of read depths across samples. Nimblegen performance was similar at read depths at 20x and below. Both Raindance and Nimblegen SeqCap exhibited tighter distributions of read depth around the mean, but both suffered from lower on-target efficiency in our experiments. Raindance demonstrated the highest versatility in assay design. FAU - Hedges, Dale J AU - Hedges DJ AD - John T. MacDonald Department of Human Genetics, Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, United States of America. dhedges@med.miami.edu FAU - Guettouche, Toumy AU - Guettouche T FAU - Yang, Shan AU - Yang S FAU - Bademci, Guney AU - Bademci G FAU - Diaz, Ashley AU - Diaz A FAU - Andersen, Ashley AU - Andersen A FAU - Hulme, William F AU - Hulme WF FAU - Linker, Sara AU - Linker S FAU - Mehta, Arpit AU - Mehta A FAU - Edwards, Yvonne J K AU - Edwards YJ FAU - Beecham, Gary W AU - Beecham GW FAU - Martin, Eden R AU - Martin ER FAU - Pericak-Vance, Margaret A AU - Pericak-Vance MA FAU - Zuchner, Stephan AU - Zuchner S FAU - Vance, Jeffery M AU - Vance JM FAU - Gilbert, John R AU - Gilbert JR LA - eng GR - 3P50NS071674-01S1/NS/NINDS NIH HHS/United States GR - RC2 HG005605/HG/NHGRI NIH HHS/United States GR - 1RC2HG005605/HG/NHGRI NIH HHS/United States GR - P50 NS071674/NS/NINDS NIH HHS/United States GR - R01 NS072248/NS/NINDS NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20110429 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (DNA Primers) SB - IM MH - Alleles MH - Base Sequence MH - Computational Biology/methods MH - DNA Primers/chemistry MH - Female MH - Genotype MH - Heterozygote MH - Humans MH - Male MH - Molecular Sequence Data MH - Nucleic Acid Hybridization MH - Polymerase Chain Reaction/methods MH - Reproducibility of Results MH - Sequence Analysis, DNA/*methods MH - Software PMC - PMC3084696 COIS- Competing Interests: A portion of the reagents used in this study was provided free of charge by the participating vendors, including Roche-Nimblegen, Raindance, Agilent, and Applied Biosystems. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. EDAT- 2011/05/12 06:00 MHDA- 2011/12/13 00:00 PMCR- 2011/04/29 CRDT- 2011/05/12 06:00 PHST- 2011/01/05 00:00 [received] PHST- 2011/03/04 00:00 [accepted] PHST- 2011/05/12 06:00 [entrez] PHST- 2011/05/12 06:00 [pubmed] PHST- 2011/12/13 00:00 [medline] PHST- 2011/04/29 00:00 [pmc-release] AID - PONE-D-11-01617 [pii] AID - 10.1371/journal.pone.0018595 [doi] PST - epublish SO - PLoS One. 2011 Apr 29;6(4):e18595. doi: 10.1371/journal.pone.0018595.